Carnegie Mellon University

Exploring technology to combat diseases

Digital Vaccines are a subcategory of digital therapeutics , which are evidence-based prevention approaches that use digital technologies (applications delivered via smart-phones, tablets, etc.) for nudging positive human behavior via neurocognitive training.
They are gamified, digital interventions that draw from principles of neuroscience, psychology, Artificial Intelligence (AI), persuasive computing and behavioral economics to provide safe and low-risk mechanisms for dynamic neuro-behavioral-physiological modulation.
fooya picture

The emerging world of digital therapeutics

The treatment of many physical and mental health conditions is going digital.

fooya photo

Can kids game their way to better health?

Heinz College Trustees Professor, Rema Padman, talks about her research on testing the effects of an AI-enabled, app-based game—a neurocognitive Digital Vaccine—on healthy food choices to prevent lifestyle diseases.

 

 

nerve cell photo

Bhargav Sri Prakash, Founder & CEO, FriendsLearn Inc explains the concept of a digital vaccine and how it works.

An interview with Bhargav Sri Prakash, the Digital Vaccine project's technology partner. 


 

Coronavirus

Digital Vaccine for COVID-19

A brief discussion on the development of a Digital Vaccine Candidate for COVID-19 and its Evaluation via a Human Field Trial. 

injection photo

AI-enabled vaccines for diabetes, heart disease and cancer featured as top technology breakthrough by Carnegie Mellon University

Read about FriendsLearn's efforts in pioneering a new category of AI-VR enabled Digital Vaccines. The SF based start-up is collaborating with renowned scientific collaborators from Carnegie Mellon University, Johns Hopkins University Bloomberg School of Public Health, Stanford School of Medicine, Stanford Law School, The University of Michigan – Ann Arbor, Pittsburgh Children’s Hospital of UPMC, Oxford University Nuffield School of Medicine, National University of Singapore, Baylor College of Medicine,  & Kansas Medical Center. 
remapadman.jpg

Dr. Rema Padman

Dr. Padman is leading the research on Digital Vaccines, a sub-category of digital therapeutics, to promote healthier lifestyle choices. She is the Trustees Professor of Management Science and Healthcare Informatics at Heinz College of Information Systems and Public Policy at Carnegie Mellon University in Pittsburgh. She is also Thrust Leader of Healthcare Informatics Research at iLab and Research Area Director for Operations and Informatics at the Center for Health Analytics at the Heinz College, and Adjunct Professor in the Department of Biomedical Informatics at the University of Pittsburgh School of Medicine. She received B.Tech. in Chemical Engineering from the Indian Institute of Technology, Kanpur, India, PhD in Operations Research from the University of Texas at Austin and National Library of Medicine Senior Fellowship in Applied Informatics from The University of Pittsburgh School of Medicine.
Contact her at rpadman@cmu.edu to learn more about or collaborate on Digital Vaccine research.